Erythromycin EP Impurity L
Additional information on Erythromycin EP Impurity L
VL690014
N/A
C37H65NO14
747.92
Erythromycin
(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-[(2, 6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7, 12, 13-trihydroxy-3, 5, 7, 9, 11, 13-hexamethyl-6-[[3, 4, 6-trideoxy-3-(formylmethylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2, 10-dione
3″-N-demethyl-3″-N-formyl erythromycin A; N-Demethyl-N-formylerythromycin; Oxacyclotetradecane, Erythromycin Derivative; N-((2S, 3R, 4S, 6R)-2-(((3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-14-ethyl-7, 12, 13-Trihydroxy-4-(((2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3, 5, 7, 9, 11, 13-hexamethyl-2, 10-dioxooxacyclotetradecan-6-yl)oxy)-3-hydroxy-6-methyltetrahydro-2H-pyran-4-yl)-N-methylformamide
–
In-stock
Other products related to erythromycin
CAS No. | Name of Impurity | Parent Drug | Catalogue No. |
---|